ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,100Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 680

$1.16M Total Retail Price of All Prescriptions

Rank: 53 out of 680

471 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 13,394 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 582 498 1 6
LEVOTHYROXINE SODIUM 506 447 2 2
HYDROCODONE-ACETAMINOPHEN 427 279 S3 3 4
OMEPRAZOLE 411 325 4 7
SIMVASTATIN 386 348 5 3
AMLODIPINE BESYLATE 330 276 6 1
NAMENDA 298 289 7 35
DONEPEZIL HCL 290 282 8 27
GABAPENTIN 279 203 9 15
METOPROLOL TARTRATE 264 222 10 12
LISINOPRIL 263 213 11 5
ZOLPIDEM TARTRATE 249 186 12 17
METFORMIN HCL 242 195 13 8
KLOR-CON M20 233 184 14 61
NEXIUM 230 157 15 16
SERTRALINE HCL 220 161 16 28
CITALOPRAM HBR 216 179 17 22
WARFARIN SODIUM 213 160 18 20
TRAZODONE HCL 190 121 19 48
PREDNISONE 181 151 20 50
RISPERIDONE 178 121 21 80
MEGESTROL ACETATE 175 148 R 22 88
TAMSULOSIN HCL 173 158 23 34
LANTUS 167 133 24 49
CLOPIDOGREL 167 132 24 26
TRAMADOL HCL 154 116 26 18
ESCITALOPRAM OXALATE 137 96 27 45
LEVOFLOXACIN 135 101 28 97
POTASSIUM CHLORIDE 135 129 28 14
PRAVASTATIN SODIUM 132 118 30 10
HYDROCHLOROTHIAZIDE 128 125 31 9
CYMBALTA 127 72 32 46
CARVEDILOL 123 102 33 23
ATENOLOL 119 99 34 19
CLONIDINE HCL 115 105 35 36
NITROFURANTOIN MONO-MACRO 115 99 35 172
OLANZAPINE 115 93 35 116
PANTOPRAZOLE SODIUM 114 85 38 30
METOPROLOL SUCCINATE 110 98 39 13
MELOXICAM 108 99 40 24
RANITIDINE HCL 108 102 40 56
MIRTAZAPINE 106 85 42 78
POLYETHYLENE GLYCOL 3350 103 80 43 62
CIPROFLOXACIN HCL 100 84 44 57
AMITRIPTYLINE HCL 97 68 R 45 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 72 46 94
EXELON 94 93 47 112
AZITHROMYCIN 92 79 48 42
ALLOPURINOL 92 64 48 33
FLUTICASONE PROPIONATE 91 84 50 41
LYRICA 91 86 50 77
PLAVIX 90 76 52 39
DIVALPROEX SODIUM ER 88 48 53 148
PROMETHAZINE HCL 87 30 R 54 96
GLIMEPIRIDE 83 57 55 29
IPRATROPIUM-ALBUTEROL 83 66 55 207
DIOVAN 81 81 57 31
ATORVASTATIN CALCIUM 80 60 58 11
DOXYCYCLINE HYCLATE 80 63 58 95
QUETIAPINE FUMARATE 79 60 60 64
LOSARTAN POTASSIUM 78 66 61 21
PHENYTOIN SODIUM EXTENDED 75 47 62 115
ROPINIROLE HCL 75 28 62 99
LABETALOL HCL 74 69 64 158
NOVOLIN R 73 56 65 113
OXYCODONE HCL-ACETAMINOPHEN 71 35 S2 66 133
ALBUTEROL SULFATE 70 66 67 154
TRIAMTERENE-HCTZ 70 65 67 52
FELODIPINE ER 68 66 69 146
BENZTROPINE MESYLATE 67 19 R 70 137
GLIPIZIDE 67 65 70 63
KLOR-CON M10 66 47 72 127
ABILIFY 64 38 73 178
OXYBUTYNIN CHLORIDE ER 64 64 73 143
PAROXETINE HCL 64 54 73 76
FINASTERIDE 63 53 76 109
SINGULAIR 62 47 77 91
CARBIDOPA-LEVODOPA 61 52 78 117
IPRATROPIUM BROMIDE 61 59 78 211
QUINAPRIL HCL 60 49 80 104
DIGOXIN 59 55 81 58
FLUCONAZOLE 59 45 81 139
MEGACE ES 58 46 R 83 280
LEVETIRACETAM 57 27 84 120
LIDODERM 56 35 85 221
METHOCARBAMOL 56 33 R 85 251
CRESTOR 55 36 87 25
CARISOPRODOL 55 12 R 87 83
LEXAPRO 54 41 89 128
ADVAIR DISKUS 53 27 90 53
METOCLOPRAMIDE HCL 53 26 90 118
CYCLOBENZAPRINE HCL 50 26 R 92 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.